| Year |
Citation |
Score |
| 2022 |
Ravindranathan S, Passang T, Li JM, Wang S, Dhamsania R, Ware MB, Zaidi MY, Zhu J, Cardenas M, Liu Y, Gumber S, Robinson B, Sen-Majumdar A, Zhang H, Chandrakasan S, ... ... Frey AB, et al. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nature Communications. 13: 6418. PMID 36302761 DOI: 10.1038/s41467-022-34242-4 |
0.525 |
|
| 2018 |
Burgess HM, Pourchet A, Hajdu CH, Chiriboga L, Frey AB, Mohr I. Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus. Molecular Therapy Oncolytics. 8: 71-81. PMID 29888320 DOI: 10.1016/J.Omto.2018.01.001 |
0.336 |
|
| 2017 |
Frey AB. The inhibitory signaling receptor protocadherin-18 regulates tumor infiltrating CD8+ T cell function. Cancer Immunology Research. PMID 28874354 DOI: 10.1158/2326-6066.Cir-17-0187 |
0.698 |
|
| 2016 |
Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S, Rodriguez PC, Sica A, Umansky V, Vonderheide RH, Gabrilovich DI. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nature Communications. 7: 12150. PMID 27381735 DOI: 10.1038/Ncomms12150 |
0.398 |
|
| 2016 |
Moogk D, Zhong S, Yu Z, Liadi I, Rittase W, Fang V, Dougherty J, Perez-Garcia A, Osman I, Zhu C, Varadarajan N, Restifo NP, Frey AB, Krogsgaard M. Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets. Journal of Immunology (Baltimore, Md. : 1950). PMID 27271569 DOI: 10.4049/Jimmunol.1600178 |
0.542 |
|
| 2016 |
Pourchet A, Fuhrmann SR, Pilones KA, Demaria S, Frey AB, Mulvey M, Mohr I. CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy. Ebiomedicine. 5: 59-67. PMID 27077112 DOI: 10.1016/J.Ebiom.2016.01.022 |
0.649 |
|
| 2016 |
Yu C, Burns JC, Robinson WH, Utz PJ, Ho PP, Steinman L, Frey AB. Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model. Journal of Diabetes Research. 2016: 9083103. PMID 27069933 DOI: 10.1155/2016/9083103 |
0.431 |
|
| 2015 |
Frey AB. Suppression of T cell responses in the tumor microenvironment. Vaccine. PMID 26403368 DOI: 10.1016/J.Vaccine.2015.08.096 |
0.643 |
|
| 2015 |
Pourchet A, Fuhrmann SR, Pilones KA, Demaria S, Frey AB, Mulvey M, Mohr I. CD8+ T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy Ebiomedicine. DOI: 10.1016/j.ebiom.2016.01.022 |
0.432 |
|
| 2014 |
Zhong S, Malecek K, Moogk D, Johnson LA, Yu Z, Grigoryan A, Vega-Saenz de Miera E, Darvishian F, Gu W, McGary K, Huang K, Boyer J, Corse E, Yongzhao S, Rosenberg SA, ... ... Frey A, et al. Engineering the immune response to "self" for effective cancer immunotherapy Journal For Immunotherapy of Cancer. 2: P22. DOI: 10.1186/2051-1426-2-S3-P22 |
0.422 |
|
| 2012 |
Monu NR, Frey AB. Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship. Immunological Investigations. 41: 595-613. PMID 23017137 DOI: 10.3109/08820139.2012.673191 |
0.826 |
|
| 2012 |
Weiss JM, Bilate AM, Gobert M, Ding Y, Curotto de Lafaille MA, Parkhurst CN, Xiong H, Dolpady J, Frey AB, Ruocco MG, Yang Y, Floess S, Huehn J, Oh S, Li MO, et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. The Journal of Experimental Medicine. 209: 1723-42, S1. PMID 22966001 DOI: 10.1084/Jem.20120914 |
0.503 |
|
| 2012 |
Ochi A, Nguyen AH, Bedrosian AS, Mushlin HM, Zarbakhsh S, Barilla R, Zambirinis CP, Fallon NC, Rehman A, Pylayeva-Gupta Y, Badar S, Hajdu CH, Frey AB, Bar-Sagi D, Miller G. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. The Journal of Experimental Medicine. 209: 1671-87. PMID 22908323 DOI: 10.1084/Jem.20111706 |
0.396 |
|
| 2012 |
Ibrahim J, Nguyen AH, Rehman A, Ochi A, Jamal M, Graffeo CS, Henning JR, Zambirinis CP, Fallon NC, Barilla R, Badar S, Mitchell A, Rao RS, Acehan D, Frey AB, et al. Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology. 143: 1061-72. PMID 22705178 DOI: 10.1053/J.Gastro.2012.06.003 |
0.384 |
|
| 2012 |
Vazquez-Cintron EJ, Monu NR, Burns JC, Blum R, Chen G, Lopez P, Ma J, Radoja S, Frey AB. Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells. Plos One. 7: e36101. PMID 22567129 DOI: 10.1371/Journal.Pone.0036101 |
0.778 |
|
| 2011 |
Bedrosian AS, Nguyen AH, Hackman M, Connolly MK, Malhotra A, Ibrahim J, Cieza-Rubio NE, Henning JR, Barilla R, Rehman A, Pachter HL, Medina-Zea MV, Cohen SM, Frey AB, Acehan D, et al. Dendritic cells promote pancreatic viability in mice with acute pancreatitis. Gastroenterology. 141: 1915-26.e1-14. PMID 21801698 DOI: 10.1053/J.Gastro.2011.07.033 |
0.375 |
|
| 2010 |
Vazquez-Cintron EJ, Monu NR, Frey AB. Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phase. Journal of Immunology (Baltimore, Md. : 1950). 185: 7133-40. PMID 21127315 DOI: 10.4049/Jimmunol.1001157 |
0.839 |
|
| 2010 |
Connolly MK, Bedrosian AS, Malhotra A, Henning JR, Ibrahim J, Vera V, Cieza-Rubio NE, Hassan BU, Pachter HL, Cohen S, Frey AB, Miller G. In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity. Journal of Immunology (Baltimore, Md. : 1950). 185: 2200-8. PMID 20639479 DOI: 10.4049/Jimmunol.1000332 |
0.381 |
|
| 2010 |
Connolly MK, Mallen-St Clair J, Bedrosian AS, Malhotra A, Vera V, Ibrahim J, Henning J, Pachter HL, Bar-Sagi D, Frey AB, Miller G. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. Journal of Leukocyte Biology. 87: 713-25. PMID 20042467 DOI: 10.1189/Jlb.0909607 |
0.523 |
|
| 2009 |
Connolly MK, Bedrosian AS, Mallen-St Clair J, Mitchell AP, Ibrahim J, Stroud A, Pachter HL, Bar-Sagi D, Frey AB, Miller G. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. The Journal of Clinical Investigation. 119: 3213-25. PMID 19855130 DOI: 10.1172/Jci37581 |
0.349 |
|
| 2008 |
Nonaka K, Saio M, Suwa T, Frey AB, Umemura N, Imai H, Ouyang GF, Osada S, Balazs M, Adany R, Kawaguchi Y, Yoshida K, Takami T. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. Journal of Leukocyte Biology. 84: 679-88. PMID 18566103 DOI: 10.1189/Jlb.1107729 |
0.579 |
|
| 2008 |
Frey AB, Monu N. Signaling defects in anti-tumor T cells. Immunological Reviews. 222: 192-205. PMID 18364003 DOI: 10.1111/J.1600-065X.2008.00606.X |
0.84 |
|
| 2008 |
Frey AB. Cancer-Induced Signaling Defects in Antitumor T Cells Immunological Reviews. 222: 69-100. DOI: 10.1007/978-0-387-69118-3_5 |
0.586 |
|
| 2007 |
Monu N, Frey AB. Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells. Cancer Research. 67: 11447-54. PMID 18056473 DOI: 10.1158/0008-5472.Can-07-1441 |
0.864 |
|
| 2007 |
Ma JS, Monu N, Shen DT, Mecklenbräuker I, Radoja N, Haydar TF, Leitges M, Frey AB, Vukmanovic S, Radoja S. Protein kinase Cdelta regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTL. Journal of Immunology (Baltimore, Md. : 1950). 178: 7814-21. PMID 17548619 DOI: 10.4049/Jimmunol.178.12.7814 |
0.82 |
|
| 2007 |
Nakagawa J, Saio M, Tamakawa N, Suwa T, Frey AB, Nonaka K, Umemura N, Imai H, Ouyang GF, Ohe N, Yano H, Yoshimura S, Iwama T, Takami T. TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma. International Journal of Oncology. 30: 803-11. PMID 17332918 DOI: 10.3892/Ijo.30.4.803 |
0.525 |
|
| 2006 |
Frey AB. Myeloid suppressor cells regulate the adaptive immune response to cancer. The Journal of Clinical Investigation. 116: 2587-90. PMID 17016554 DOI: 10.1172/Jci29906 |
0.555 |
|
| 2006 |
Radoja S, Frey AB, Vukmanovic S. T-cell receptor signaling events triggering granule exocytosis. Critical Reviews in Immunology. 26: 265-90. PMID 16928189 DOI: 10.1615/Critrevimmunol.V26.I3.40 |
0.818 |
|
| 2006 |
Koneru M, Monu N, Schaer D, Barletta J, Frey AB. Defective adhesion in tumor infiltrating CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 176: 6103-11. PMID 16670319 DOI: 10.4049/Jimmunol.176.10.6103 |
0.81 |
|
| 2006 |
Frey AB, Monu N. Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response. Journal of Leukocyte Biology. 79: 652-62. PMID 16415165 DOI: 10.1189/Jlb.1105628 |
0.831 |
|
| 2005 |
Koneru M, Schaer D, Monu N, Ayala A, Frey AB. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function. Journal of Immunology (Baltimore, Md. : 1950). 174: 1830-40. PMID 15699109 DOI: 10.4049/Jimmunol.174.4.1830 |
0.812 |
|
| 2004 |
Saio M, Teicher M, Campbell G, Feiner H, Delgado Y, Frey AB. Immunocytochemical demonstration of down regulation of HLA class-I molecule expression in human metastatic breast carcinoma. Clinical & Experimental Metastasis. 21: 243-9. PMID 15387374 DOI: 10.1023/B:Clin.0000037707.07428.Ff |
0.355 |
|
| 2002 |
Lilić M, Santori FR, Neilson EG, Frey AB, Vukmanović S. The role of fibroblasts in thymocyte-positive selection. Journal of Immunology (Baltimore, Md. : 1950). 169: 4945-50. PMID 12391207 DOI: 10.4049/Jimmunol.169.9.4945 |
0.405 |
|
| 2002 |
Caragine TA, Imai M, Frey AB, Tomlinson S. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity. Blood. 100: 3304-10. PMID 12384431 DOI: 10.1182/Blood.V100.9.3304 |
0.385 |
|
| 2002 |
Caragine TA, Okada N, Frey AB, Tomlinson S. A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer. Cancer Research. 62: 1110-5. PMID 11861390 |
0.449 |
|
| 2001 |
Saio M, Radoja S, Marino M, Frey AB. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. Journal of Immunology (Baltimore, Md. : 1950). 167: 5583-93. PMID 11698429 DOI: 10.4049/Jimmunol.167.10.5583 |
0.846 |
|
| 2001 |
Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, Frey AB. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. Journal of Immunology (Baltimore, Md. : 1950). 167: 5042-51. PMID 11673513 DOI: 10.4049/Jimmunol.167.9.5042 |
0.803 |
|
| 2001 |
Radoja S, Saio M, Frey AB. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. Journal of Immunology (Baltimore, Md. : 1950). 166: 6074-83. PMID 11342625 DOI: 10.4049/Jimmunol.166.10.6074 |
0.84 |
|
| 2000 |
Lee CK, Rao DT, Gertner R, Gimeno R, Frey AB, Levy DE. Distinct requirements for IFNs and STAT1 in NK cell function Journal of Immunology. 165: 3571-3577. PMID 11034357 DOI: 10.4049/Jimmunol.165.7.3571 |
0.453 |
|
| 2000 |
Durbin JE, Fernandez-Sesma A, Lee CK, Rao TD, Frey AB, Moran TM, Vukmanovic S, García-Sastre A, Levy DE. Type I IFN modulates innate and specific antiviral immunity. Journal of Immunology (Baltimore, Md. : 1950). 164: 4220-8. PMID 10754318 DOI: 10.4049/Jimmunol.164.8.4220 |
0.334 |
|
| 2000 |
Radoja S, Rao TD, Hillman D, Frey AB. Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivo. Journal of Immunology (Baltimore, Md. : 1950). 164: 2619-28. PMID 10679101 DOI: 10.4049/Jimmunol.164.5.2619 |
0.854 |
|
| 2000 |
Finke J, Ferrone S, Frey A, Mufson A, Ochoa A. Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunology Today. 20: 158-60. PMID 10203710 DOI: 10.1016/S0167-5699(98)01435-2 |
0.545 |
|
| 2000 |
Radoja S, Frey AB. Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing Molecular Medicine. 6: 465-479. DOI: 10.1007/Bf03401788 |
0.852 |
|
| 1999 |
Frey AB, Rao TD. NKT cell cytokine imbalance in murine diabetes mellitus. Autoimmunity. 29: 201-14. PMID 10433100 DOI: 10.3109/08916939908998535 |
0.477 |
|
| 1999 |
Wood SC, Rao TD, Frey AB. Multidose streptozotocin induction of diabetes in BALB/cBy mice induces a T cell proliferation defect in thymocytes which is reversible by interleukin-4. Cellular Immunology. 192: 1-12. PMID 10066341 DOI: 10.1006/Cimm.1998.1413 |
0.347 |
|
| 1998 |
Lopez CB, Rao TD, Feiner H, Shapiro R, Marks JR, Frey AB. Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes. Cellular Immunology. 190: 141-55. PMID 9878115 DOI: 10.1006/Cimm.1998.1390 |
0.493 |
|
| 1998 |
Rao TD, Frey AB. Soluble proteins isolated from Borrelia burgdorferi by extraction with Triton X-114 confer resistance to experimental infection. Clinical Immunology and Immunopathology. 89: 94-104. PMID 9756728 DOI: 10.1006/Clin.1998.4593 |
0.364 |
|
| 1998 |
Rao TD, Frey AB. Administration of silica sensitizes lipopolysaccharide responsiveness of murine macrophages but inhibits T and B cell priming by inhibition of antigen presenting function. Immunological Investigations. 27: 181-99. PMID 9653666 DOI: 10.3109/08820139809089455 |
0.424 |
|
| 1997 |
Frey AB, Cestari S. Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules. Cellular Immunology. 178: 79-90. PMID 9184701 DOI: 10.1006/Cimm.1997.1122 |
0.656 |
|
| 1997 |
Frey AB. Study of immune response to tumors in the rat. Methods (San Diego, Calif.). 12: 173-88. PMID 9184381 DOI: 10.1006/Meth.1997.0465 |
0.384 |
|
| 1997 |
Badovinac V, Boggiano C, Trajkovic V, Frey A, Vujanovic N, Gold D, Mostarica Stojkovic M, Vukmanovic S. Rat NT (NKR-P1+/TCRα,β+/CD8+) cells are not essential for the development of Th2 type CD4+ T cell responses Immunology Letters. 56: 387. DOI: 10.1016/S0165-2478(97)86561-3 |
0.4 |
|
| 1996 |
Appleman LJ, Frey AB. Tumors antigens encoded by oncogenes and the impact of oncogenes upon the immune responses. Cellular Immunology. 170: 1-10. PMID 8660793 DOI: 10.1006/Cimm.1996.0127 |
0.488 |
|
| 1995 |
Rao TD, Frey AB. Protective resistance to experimental Borrelia burgdorferi infection of mice by adoptive transfer of a CD4+ T cell clone. Cellular Immunology. 162: 225-34. PMID 7743550 DOI: 10.1006/Cimm.1995.1073 |
0.511 |
|
| 1995 |
Appleman LJ, Frey AB. Dominant-negative p53 can restore tumorigenicity of L-929 cells in immunocompetent mice. International Journal of Cancer. 63: 576-83. PMID 7591269 DOI: 10.1002/Ijc.2910630419 |
0.491 |
|
| 1995 |
Appleman LJ, Uyeki J, Frey AB. Mouse embryo fibroblasts transformed by activated ras or dominant-negative p53 express cross-reactive tumor rejection antigens. International Journal of Cancer. 61: 887-94. PMID 7540599 DOI: 10.1002/Ijc.2910610623 |
0.49 |
|
| 1994 |
Rao TD, Fischer A, Frey AB. CD4+ Th2 T cells elicited by immunization confer protective immunity to experimental Borrelia burgdorferi infection. Annals of the New York Academy of Sciences. 730: 364-6. PMID 7915895 DOI: 10.1111/J.1749-6632.1994.Tb44294.X |
0.483 |
|
| 1993 |
Frey AB, Appleman LJ. Rat adenocarcinoma 13762 expresses tumor rejection antigens but tumor-bearing animals exhibit tumor-specific immunosuppression. Clinical Immunology and Immunopathology. 69: 223-33. PMID 8403560 DOI: 10.1006/Clin.1993.1173 |
0.591 |
|
| 1989 |
FREY AB, LEVINE AJ. Rat Embryo Fibroblasts Transformed by p53 Plus ras Possess Tumor-specific Transplantation Activity Annals of the New York Academy of Sciences. 567: 295-298. DOI: 10.1111/J.1749-6632.1989.Tb16485.X |
0.343 |
|
| 1988 |
Clarke CF, Cheng K, Frey AB, Stein R, Hinds PW, Levine AJ. Purification of complexes of nuclear oncogene p53 with rat and Escherichia coli heat shock proteins: in vitro dissociation of hsc70 and dnaK from murine p53 by ATP Molecular and Cellular Biology. 8: 1206-1215. PMID 3285177 DOI: 10.1128/mcb.8.3.1206-1215.1988 |
0.304 |
|
| 1984 |
Frey AB, Rosenfeld MG, Dolan WJ, Adesnik M, Kreibich G. Induction of cytochrome P-450 isozymes in rat hepatoma-derived cell cultures. Journal of Cellular Physiology. 120: 169-80. PMID 6378929 DOI: 10.1002/Jcp.1041200210 |
0.341 |
|
| Show low-probability matches. |